Hinge Health Inc.’s (NYSE:HNGE) Lock-Up Period To Expire on November 18th

Hinge Health’s (NYSE:HNGE) lock-up period will expire on Tuesday, November 18th. Hinge Health had issued 13,666,000 shares in its public offering on May 22nd. The total size of the offering was $437,312,000 based on an initial share price of $32.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on HNGE shares. Wall Street Zen raised shares of Hinge Health from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Canaccord Genuity Group lifted their price target on shares of Hinge Health from $61.00 to $65.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Piper Sandler reiterated an “overweight” rating and issued a $71.00 price target (up from $70.00) on shares of Hinge Health in a research note on Wednesday, November 5th. Weiss Ratings restated a “sell (d)” rating on shares of Hinge Health in a research note on Wednesday, October 8th. Finally, Evercore ISI lifted their price objective on Hinge Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $59.93.

Hinge Health Price Performance

NYSE HNGE opened at $40.95 on Friday. The business’s fifty day simple moving average is $51.10. Hinge Health has a fifty-two week low of $33.42 and a fifty-two week high of $62.18.

Hinge Health (NYSE:HNGE) last posted its quarterly earnings results on Tuesday, November 4th. The company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.18. The business had revenue of $154.21 million for the quarter, compared to analyst estimates of $142.44 million. Hinge Health’s quarterly revenue was up 53.3% on a year-over-year basis. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health declared that its board has initiated a share buyback plan on Wednesday, November 12th that allows the company to repurchase $250.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 7.2% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

Institutional Investors Weigh In On Hinge Health

Several hedge funds and other institutional investors have recently made changes to their positions in HNGE. BIT Capital GmbH increased its position in Hinge Health by 144.6% during the 3rd quarter. BIT Capital GmbH now owns 1,849,524 shares of the company’s stock worth $90,775,000 after purchasing an additional 1,093,320 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Hinge Health by 22.6% during the third quarter. Vanguard Group Inc. now owns 1,237,839 shares of the company’s stock worth $60,753,000 after buying an additional 228,234 shares during the last quarter. Bamco Inc. NY acquired a new position in shares of Hinge Health during the second quarter worth $48,943,000. JPMorgan Chase & Co. bought a new position in shares of Hinge Health in the 2nd quarter valued at $43,840,000. Finally, Franklin Resources Inc. acquired a new stake in shares of Hinge Health during the 2nd quarter valued at $28,462,000.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.